| Literature DB >> 19383125 |
Fredrik Söderqvist1, Michael Carlberg, Lennart Hardell.
Abstract
BACKGROUND: Whether low-intensity radiofrequency radiation damages the blood-brain barrier has long been debated, but little or no consideration has been given to the blood-cerebrospinal fluid barrier. In this cross-sectional study we tested whether long-term and/or short-term use of wireless telephones was associated with changes in the serum transthyretin level, indicating altered transthyretin concentration in the cerebrospinal fluid, possibly reflecting an effect of radiation.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19383125 PMCID: PMC2679014 DOI: 10.1186/1476-069X-8-19
Source DB: PubMed Journal: Environ Health ISSN: 1476-069X Impact factor: 5.984
Descriptive data for the study
| Men | Women | Total | |
|---|---|---|---|
| Total included | 500 | 500 | 1 000 |
| -Age: mean, median | 41.8, 41.0 | 41.6, 42.0 | 41.7, 42.0 |
| Range | 18–65 | 18–65 | 18–65 |
| Declined to participate | 127 | 156 | 283 |
| Did not answer inquiry | 196 | 116 | 312 |
| Answered yes to participation | 177 | 228 | 405 |
| -Did not give blood | 44 | 44 | 88 |
| Participated | 133 | 184 | 317 |
| -Did not answer the questionnaire | 0 | 2 | 2 |
| -Unknown date for drawing blood | 0 | 1 | 1 |
| -Missing data, transthyretin | 0 | 1 | 1 |
| Final participants | 133 | 180 | 313 |
| -Age: mean, median | 47.1, 50.0 | 44.4, 46.0 | 45.6, 47.0 |
| Range | 18–65 | 18–64 | 18–65 |
Descriptive data for serum transthyretin (g/L)
| n | Mean | Median | Min | Max | p | |
|---|---|---|---|---|---|---|
| Transthyretin, total | 313 | 0.277 | 0.270 | 0.170 | 0.480 | - |
| Age (cut-point at median) | ||||||
| ≤ 47 years | 158 | 0.271 | 0.260 | 0.170 | 0.480 | 0.02 |
| > 47 years | 155 | 0.284 | 0.280 | 0.180 | 0.470 | |
| Gender | ||||||
| Men | 133 | 0.307 | 0.300 | 0.180 | 0.480 | <0.0001 |
| Women | 180 | 0.256 | 0.250 | 0.170 | 0.400 | |
| Time (hour) when blood was drawn | ||||||
| 06:00–12:00 | 65 | 0.286 | 0.270 | 0.170 | 0.420 | 0.12 |
| 12:01–16:00 | 248 | 0.275 | 0.270 | 0.170 | 0.480 | |
| Day when blood was drawn | ||||||
| Mon-Thur | 174 | 0.276 | 0.260 | 0.170 | 0.440 | 0.77 |
| Fri-Sun | 139 | 0.279 | 0.270 | 0.170 | 0.480 | |
| Month when blood was drawn | ||||||
| March-June | 228 | 0.278 | 0.270 | 0.170 | 0.480 | 0.94 |
| July-October | 85 | 0.277 | 0.270 | 0.170 | 0.400 | |
The Wilcoxon rank-sum was used to calculate p-values.
Logistic regression analysis for serum transthyretin and long-term use of wireless telephones
| Group | Total | > 5 years since first use | > 10 years since first use | ||||||
|---|---|---|---|---|---|---|---|---|---|
| H/La | OR | 95% CI | H/La | OR | 95% CI | H/La | OR | 95% CI | |
| -Mobile telephones + DECT | 56/177 | 1.2 | 0.6 – 2.4 | 56/170 | 1.2 | 0.6 – 2.5 | 40/80 | 1.5 | 0.7 – 3.1 |
| -Men | 46/58 | 1.5 | 0.6 – 3.5 | 46/57 | 1.5 | 0.6 – 3.6 | 34/39 | 1.6 | 0.6 – 3.9 |
| -Women | 10/119 | 0.8 | 0.3 – 2.6 | 10/113 | 0.8 | 0.3 – 2.7 | 6/41 | 1.3 | 0.4 – 4.6 |
| -Mobile telephones | 55/176 | 1.2 | 0.6 – 2.4 | 53/152 | 1.2 | 0.6 – 2.5 | 35/58 | 1.5 | 0.7 – 3.3 |
| -Men | 45/58 | 1.4 | 0.6 – 3.5 | 45/53 | 1.6 | 0.7 – 3.8 | 32/34 | 1.7 | 0.7 – 4.2 |
| -Women | 10/118 | 0.8 | 0.3 – 2.6 | 8/99 | 0.8 | 0.2 – 2.5 | 3/24 | 1.2 | 0.3 – 5.8 |
| -Analogue | 19/33 | 1.4 | 0.6 – 3.4 | 19/32 | 1.5 | 0.6 – 3.6 | 18/29 | 1.4 | 0.6 – 3.6 |
| -Men | 17/25 | 1.2 | 0.5 – 3.3 | 17/25 | 1.2 | 0.5 – 3.3 | 17/23 | 1.4 | 0.5 – 3.7 |
| -Women | 2/8 | 2.4 | 0.4 – 15 | 2/7 | 3.2 | 0.5 – 22 | 1/6 | 2.0 | 0.2 – 22 |
| -Digital | 55/173 | 1.2 | 0.6 – 2.5 | 53/150 | 1.3 | 0.6 – 2.6 | 32/52 | 1.6 | 0.7 – 3.6 |
| -Men | 45/56 | 1.5 | 0.6 – 3.6 | 45/52 | 1.6 | 0.7 – 3.9 | 29/29 | 1.8 | 0.7 – 4.6 |
| -Women | 10/117 | 0.8 | 0.3 – 2.6 | 8/98 | 0.8 | 0.2 – 2.5 | 3/23 | 1.3 | 0.3 – 6.0 |
| -UMTS | 13/30 | 1.0 | 0.4 – 2.9 | 0/0 | - | - | 0/0 | - | - |
| -Men | 13/17 | 1.6 | 0.5 – 5.0 | 0/0 | - | - | 0/0 | - | - |
| -Women | 0/13 | - | - | 0/0 | - | - | 0/0 | - | - |
| -DECT | 54/165 | 1.3 | 0.6 – 2.6 | 44/127 | 1.3 | 0.7 – 2.7 | 17/46 | 1.3 | 0.6 – 3.1 |
| -Men | 44/51 | 1.6 | 0.7 – 3.9 | 35/38 | 1.6 | 0.7 – 4.1 | 13/17 | 1.4 | 0.5 – 4.0 |
| -Women | 10/114 | 0.9 | 0.3 – 2.7 | 9/89 | 0.9 | 0.3 – 3.0 | 4/29 | 1.2 | 0.3 – 4.9 |
aH: Transthyretin > 0.31 g/L; L: Transthyretin ≤ 0.31 g/L.
Age was adjusted for in all analyses while adjustment for sex was applied only in analyses of total samples. 'Unexposed' were those with non-use and the quartile with the lowest overall use of mobile telephones and DECT (≤446 hours). Persons with missing information about use of wireless telephones were excluded from the analysis.
Linear regression analysis of serum transthyretin and long-term use of wireless telephones
| Group | n | Standardized β coefficient | 95% CI | p |
|---|---|---|---|---|
| -Mobile telephones + DECT | 308 | 0.08 | -0.02 to 0.18 | 0.11 |
| -Men | 132 | 0.10 | -0.07 to 0.28 | 0.24 |
| -Women | 176 | 0.09 | -0.06 to 0.23 | 0.25 |
| -Mobile telephones | 305 | 0.08 | -0.02 to 0.19 | 0.11 |
| -Men | 131 | 0.16 | -0.02 to 0.33 | 0.08 |
| -Women | 174 | -0.02 | -0.17 to 0.13 | 0.80 |
| -Analogue | 58 | 0.24 | -0.02 to 0.50 | 0.07 |
| -Men | 45 | 0.26 | -0.05 to 0.56 | 0.10 |
| -Women | 13 | 0.17 | -0.53 to 0.87 | 0.61 |
| -Digital | 302 | 0.08 | -0.02 to 0.18 | 0.13 |
| -Men | 130 | 0.15 | -0.03 to 0.32 | 0.10 |
| -Women | 172 | -0.01 | -0.16 to 0.14 | 0.85 |
| -UMTS | 49 | -0.11 | -0.38 to 0.15 | 0.41 |
| -Men | 31 | -0.18 | -0.54 to 0.17 | 0.31 |
| -Women | 18 | 0.32 | -0.29 to 0.92 | 0.28 |
| -DECT | 279 | 0.04 | -0.07 to 0.14 | 0.50 |
| -Men | 117 | -0.13 | -0.31 to 0.06 | 0.17 |
| -Women | 162 | 0.10 | -0.05 to 0.25 | 0.18 |
| Mobile telephones + DECT | 309 | 0.13 | 0.02 to 0.24 | 0.03 |
| -Men | 133 | 0.19 | 0.01 to 0.38 | 0.04 |
| -Women | 176 | 0.10 | -0.05 to 0.25 | 0.20 |
| -Mobile telephones | 306 | 0.09 | -0.03 to 0.20 | 0.13 |
| -Men | 132 | 0.20 | 0.01 to 0.38 | 0.04 |
| -Women | 174 | 0.01 | -0.14 to 0.16 | 0.90 |
| -Analogue | 59 | 0.34 | 0.07 to 0.61 | 0.01 |
| -Men | 46 | 0.33 | 0.01 to 0.64 | 0.045 |
| -Women | 13 | 0.48 | -0.18 to 1.14 | 0.14 |
| -Digital | 302 | 0.06 | -0.05 to 0.17 | 0.29 |
| -Men | 130 | 0.14 | -0.05 to 0.33 | 0.14 |
| - Women | 172 | 0.03 | -0.12 to 0.17 | 0.74 |
| -UMTS | 49 | -0.04 | -0.30 to 0.23 | 0.78 |
| -Men | 31 | -0.38 | -0.71 to -0.06 | 0.02 |
| -Women | 18 | 0.48 | 0.01 to 0.94 | 0.047 |
| -DECT | 279 | 0.05 | -0.05 to 0.16 | 0.33 |
| -Men | 117 | 0.02 | -0.17 to 0.20 | 0.85 |
| -Women | 162 | 0.09 | -0.07 to 0.24 | 0.26 |
Age was adjusted for in all analyses while adjustment for sex was applied only in analyses of total samples.
Data for cumulative use of mobile telephone/DECT are missing for two persons (one had used only a mobile telephone, the other had used both a mobile telephone and DECT). Data for latency of mobile telephone/DECT are missing for one person (a user of both mobile telephone and DECT).
Logistic regression analysis of serum transthyretin and short-term use of wireless telephones
| Group | OR | 95% CI | |
|---|---|---|---|
| Mobile telephones + DECT | 55/156 | 1.4 | 0.7 – 2.8 |
| -Men | 47/55 | 1.8 | 0.8 – 4.3 |
| -Women | 8/101 | 0.9 | 0.3 – 2.8 |
| -Mobile telephones | 46/117 | 1.5 | 0.7 – 3.0 |
| -Men | 42/43 | 2.1 | 0.9 – 5.1 |
| -Women | 4/74 | 0.6 | 0.2 – 2.3 |
| -DECT | 20/79 | 1.2 | 0.5 – 2.5 |
| -Men | 15/26 | 1.2 | 0.5 – 3.3 |
| -Women | 5/53 | 1.0 | 0.3 – 3.6 |
aH: Transthyretin > 0.31 g/L; L: Transthyretin ≤ 0.31 g/L.
Age was adjusted for in all analyses while adjustment for sex was applied only in analyses of total samples.
Linear regression analysis of serum transthyretin and short-term use of wireless telephones
| Group | n | Standardized β coefficient | 95% CI | p |
|---|---|---|---|---|
| Mobile telephones | 163 | 0.01 | -0.13 to 0.14 | 0.94 |
| -Men | 85 | 0.001 | -0.22 to 0.22 | 0.99 |
| -Women | 78 | 0.03 | -0.20 to 0.25 | 0.82 |
| DECT | 99 | -0.03 | -0.21 to 0.15 | 0.72 |
| -Men | 41 | 0.01 | -0.32 to 0.34 | 0.97 |
| -Women | 58 | -0.07 | -0.33 to 0.19 | 0.59 |
| Mobile telephones + DECT | 205 | -0.11 | -0.23 to 0.01 | 0.06 |
| -Men | 98 | -0.07 | -0.27 to 0.14 | 0.51 |
| -Women | 107 | -0.21 | -0.40 to -0.02 | 0.03 |
| -Mobile telephones | 159 | -0.08 | -0.21 to 0.06 | 0.25 |
| -Men | 82 | 0.04 | -0.18 to 0.26 | 0.72 |
| -Women | 77 | -0.25 | -0.47 to -0.03 | 0.03 |
| -DECT | 97 | -0.12 | -0.30 to 0.06 | 0.20 |
| -Men | 40 | -0.14 | -0.47 to 0.19 | 0.40 |
| -Women | 57 | -0.13 | -0.39 to 0.13 | 0.33 |
Age was adjusted for in all analyses while adjustment for sex was applied only in analyses of total samples.
Data for minutes from last use of mobile telephone/DECT to blood sampling are missing for six persons (four had used a mobile telephone, two had used DECT).